Skip to main content
Livermore
Livermore
ZHEN

Syros Pharmaceuticals, Inc.

SYRSDelisted Mar 10, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001556263

Syros Pharmaceuticals, Inc. was delisted on Mar 10, 2025; its insiders filed their last Form 4 on Dec 4, 2024; 44 institutions reported holding it in 13F filings for Q4 2024, worth $1.20M in total; no superinvestor held it.

13F holders, Q3 2023

Institutional positions in Syros Pharmaceuticals, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
48
−3 vs. Q2 2023
Shares held
12.1M
+1.51M (+14.3%) vs. Q2 2023
Total value
$47.9M
+$14.5M (+43.2%) vs. Q2 2023
New holders
3
13 more added
Sold out
6
8 more reduced

2 institutions that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting SYRS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2023: 48 institutions
Q1 2021: 106 institutionsQ2 2021: 100 institutionsQ3 2021: 100 institutionsQ4 2021: 90 institutionsQ1 2022: 94 institutionsQ2 2022: 69 institutionsQ3 2022: 53 institutionsQ4 2022: 57 institutionsQ1 2023: 59 institutionsQ2 2023: 53 institutionsQ3 2023: 48 institutionsQ4 2023: 58 institutionsQ1 2024: 75 institutionsQ2 2024: 70 institutionsQ3 2024: 65 institutionsQ4 2024: 44 institutionsQ1 2025: 7 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ3 2023: $47.9M
Q1 2021: $475.8MQ2 2021: $276.0MQ3 2021: $223.1MQ4 2021: $166.0MQ1 2022: $53.1MQ2 2022: $34.2MQ3 2022: $59.9MQ4 2022: $37.9MQ1 2023: $27.5MQ2 2023: $33.5MQ3 2023: $47.9MQ4 2023: $146.8MQ1 2024: $111.9MQ2 2024: $105.2MQ3 2024: $40.8MQ4 2024: $1.20MQ1 2025: $12.4KQ2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding SYRS and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20257$12.4K
Q4 202444$1.20M
Q3 202465$40.8M
Q2 202470$105.2M
Q1 202475$111.9M
Q4 202358$146.8M
Q3 202348$47.9M
Q2 202353$33.5M
Q1 202359$27.5M
Q4 202257$37.9M
Q3 202253$59.9M
Q2 202269$34.2M
Q1 202294$53.1M
Q4 202190$166.0M
Q3 2021100$223.1M
Q2 2021100$276.0M
Q1 2021106$475.8M

Institutions, Q3 2023

Shares, value and share of portfolio for each institution holding Syros Pharmaceuticals, Inc.; share changes are against Q2 2023.

Institutions holding SYRS in Q3 2023
InstitutionSharesValue% of portfolioChange in sharesAction
CWM, LLC18$00.00%−7−28.0%Reduced
Farther Finance Advisors, LLC20$790.00%00.0%Unchanged
Bank of America Corp68$2690.00%−1−1.4%Reduced
Sound Income Strategies, LLC76$3000.00%00.0%Unchanged
Fifth Third Bancorp129$5100.00%00.0%Unchanged
Advisor Group Holdings, Inc.296$1.17K0.00%+73+32.7%Added
FMR LLC346$1.37K0.00%+249+256.7%Added
IFP Advisors, Inc438$1.73K0.00%00.0%Unchanged
Wells Fargo & Company641$2.53K0.00%−104−14.0%Reduced
Rhumbline Advisers659$2.60K0.00%00.0%Unchanged
Russell Investments Group, Ltd.750$2.96K0.00%00.0%Unchanged
Royal Bank of Canada942$4.00K0.00%−559−37.2%Reduced
JPMorgan Chase & Co1,077$4.25K0.00%+481+80.7%Added
UBS Group AG1,093$4.32K0.00%+1,093New
The PNC Financial Services Group, Inc.1,095$4.33K0.00%00.0%Unchanged
Group One Trading, L.P.1,279$5.05K0.00%00.0%Unchanged
Edmond de Rothschild Holding S.A.4,382$17.3K0.00%00.0%Unchanged
Morgan Stanley4,698$18.6K0.00%−1,876−28.5%Reduced
HighTower Advisors, LLC15,004$59.0K0.00%00.0%Unchanged
CIBC Asset Management Inc15,398$60.8K0.00%00.0%Unchanged
Clarius Group, LLC18,620$73.5K0.01%+18,620New
1492 Capital Management LLC21,744$85.9K0.06%00.0%Unchanged
Price T Rowe Associates Inc22,550$90.0K0.00%00.0%Unchanged
Shay Capital LLC23,776$93.9K0.03%−2,650−10.0%Reduced
Assenagon Asset Management S.A.25,130$99.3K0.00%+14,754+142.2%Added
Northern Trust Corp26,394$104.3K0.00%+5,667+27.3%Added
CI Private Wealth, LLC26,666$105.3K0.00%00.0%Unchanged
State Street Corp33,130$130.9K0.00%00.0%Unchanged
Bridgeway Capital Management, LLC39,500$156.0K0.00%00.0%Unchanged
Renaissance Technologies LLC49,235$194.0K0.00%+3,100+6.7%Added
LGT Capital Partners Ltd.55,000$217.3K0.01%00.0%Unchanged
LPL Financial LLC90,175$356.2K0.00%−3,900−4.1%Reduced
Knott David M Jr105,975$419.0K0.17%+9,715+10.1%Added
Goldman Sachs Group Inc106,532$420.8K0.00%+1,111+1.1%Added
ExodusPoint Capital Management, LP108,137$427.0K0.01%−10,261−8.7%Reduced
Geode Capital Management, LLC137,865$544.7K0.00%+8,002+6.2%Added
BlackRock Inc.245,745$970.7K0.00%+34,681+16.4%Added
Omega Fund Management, LLC251,270$992.5K0.91%00.0%Unchanged
DAFNA Capital Management LLC265,878$1.05M0.33%00.0%Unchanged
Vanguard Group Inc528,192$2.09M0.00%+30,984+6.2%Added
Adage Capital Partners GP, L.L.C.721,914$2.85M0.01%00.0%Unchanged
Deep Track Capital, LP828,485$3.27M0.13%+828,485New
Samsara BioCapital, LLC881,450$3.48M1.07%00.0%Unchanged
Flagship Pioneering Inc.993,848$3.93M0.28%00.0%Unchanged
CHI Advisors LLC1,299,359$5.12M2.03%+531,914+69.3%Added
Artal Group S.A.1,475,744$5.83M0.25%00.0%Unchanged
Avidity Partners Management LP1,581,142$6.25M0.25%+117,108+8.0%Added
Bain Capital Life Sciences Investors, LLC2,124,694$8.39M0.94%00.0%Unchanged
Gsa Capital Partners LLP0$00.00%−27,460−100.0%Sold out
Two Sigma Investments, LP0$00.00%−19,584−100.0%Sold out
Millennium Management LLC0$00.00%−12,825−100.0%Sold out
Dimensional Fund Advisors LP0$00.00%−12,015−100.0%Sold out
CarsonAllaria Wealth Management, Ltd.0$00.00%−104−100.0%Sold out
Signaturefd, LLC0$00.00%−87−100.0%Sold out
First Capital Advisors Group, LLC.––––Not filed
Cowen Prime Advisors LLC––––Not filed